234 related articles for article (PubMed ID: 4804293)
21. Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy.
Davies CJ; Meredith ID; Robins RA; Blamey RW; Baldwin RW
Clin Oncol; 1978 Sep; 4(3):227-34. PubMed ID: 750125
[No Abstract] [Full Text] [Related]
22. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
23. Formalinized tumour cells in the leucocyte migration inhibition test.
Ross CE; Cochran AJ; Hoyle DE; Grant RM; Mackie RM
Clin Exp Immunol; 1975 Oct; 22(1):126-32. PubMed ID: 1212813
[TBL] [Abstract][Full Text] [Related]
24. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
[No Abstract] [Full Text] [Related]
25. Immunodiagnosis of a metastasis in a patient with a history of double malignant disease.
Gardner MA; Maluish A; Halliday WJ; Clunie GJ
Med J Aust; 1975 Apr; 1(14):446-8. PubMed ID: 1160704
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
[TBL] [Abstract][Full Text] [Related]
27. The LMI test in colon, breast and lung cancer long survivors.
Fazio M; Calabrese F; Coluccia C; Giacomasso S; Casadio C; Mancuso M; Negri L; Mastromatteo V
Panminerva Med; 1992; 34(2):60-4. PubMed ID: 1408329
[TBL] [Abstract][Full Text] [Related]
28. Failure to demonstrate tumour-specific leucocyte migration inhibition in vitro by cryostat sections of breast cancer tissue.
Petrini B; Bergstrand A; Wasserman J; Blomstedt B; Blomgren H; Baral E
Clin Oncol; 1977 Sep; 3(3):259-66. PubMed ID: 912961
[No Abstract] [Full Text] [Related]
29. In vitro cellular immunity in mammary carcinoma.
Jones BM; Turnbull AR
Br J Cancer; 1974 Apr; 29(4):337-9. PubMed ID: 4852381
[No Abstract] [Full Text] [Related]
30. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
[No Abstract] [Full Text] [Related]
31. Studies on antigenicity and immunogenicity of transplantable melanoma in hamster by using migration inhibition test.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):445-7. PubMed ID: 749795
[TBL] [Abstract][Full Text] [Related]
32. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
Kochetkova VA
Lab Delo; 1980; (12):744-6. PubMed ID: 6163894
[No Abstract] [Full Text] [Related]
33. Evaluation of the LAI test in patients with benign and malignant breast diseases.
Kovarík J; Lauerová L; Ninger E; Munzarová M; Feit J; Zemanová D; Wotke R
Neoplasma; 1983; 30(2):163-7. PubMed ID: 6843721
[TBL] [Abstract][Full Text] [Related]
34. Antigen-reactive cells to tumor antigens in normal and tumor patients.
Falk RE; MacGregor AB
J Surg Res; 1976 Mar; 20(3):247-53. PubMed ID: 772313
[No Abstract] [Full Text] [Related]
35. In vitro detection of cellular immunity to melanoma antigens in man by the monocyte spreading inhibition test.
Mazuran R; Mujagic H; Malenica B; Silobrcic V
Int J Cancer; 1976 Jan; 17(1):14-20. PubMed ID: 1248899
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
Cummings FJ; Heppner GH; Stolbach L; Calabresi P
Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
[No Abstract] [Full Text] [Related]
37. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
Cervantes C; Muzio E; Exposito G; Garcia ME
Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of cellular immunity in melanoma by means of a modified leukocyte migration inhibition test].
Bowszyc J; Bowszyc J; Wojnerowicz-Grajewska M; Milanowski L
Przegl Dermatol; 1980; 67(3):319-23. PubMed ID: 6968922
[No Abstract] [Full Text] [Related]
39. Cell-mediated immunity against malignant melanoma in monozygous twins.
Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
[No Abstract] [Full Text] [Related]
40. [Leukocyte migration inhibition reaction in melanoma].
Kovaleva VL
Vopr Onkol; 1978; 24(1):38-42. PubMed ID: 636368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
